5.12 USD
▲+0.38+1.79%
2026-08-03
市值
$165.33M
市盈率
—
EPS
-1.46
股息率
—
52 周区间
2.33 – 8.51
成交量
200.17K
Beta
1.76
目标价
8.33
52W 低 2.3352W 高 8.51
价格走势
公司简介
Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The company also offers GraftAssureCore test, a blood test ...